TY - JOUR
T1 - Abdominal Wall Transplantation
T2 - Indications and Outcomes
AU - Honeyman, Calum
AU - Dolan, Roisin
AU - Stark, Helen
AU - Fries, Charles Anton
AU - Reddy, Srikanth
AU - Allan, Philip
AU - Vrakas, Giorgios
AU - Vaidya, Anil
AU - Dijkstra, Gerard
AU - Hofker, Sijbrand
AU - Tempelman, Tallechien
AU - Werker, Paul
AU - Erdmann, Detlev
AU - Ravindra, Kadiyala
AU - Sudan, Debra
AU - Friend, Peter
AU - Giele, Henk
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12
Y1 - 2020/12
N2 - Purpose of Review: This article aims to review published outcomes associated with full-thickness vascularized abdominal wall transplantation, with particular emphasis on advances in the field in the last 3 years. Recent Findings: Forty-six full-thickness vascularized abdominal wall transplants have been performed in 44 patients worldwide. Approximately 35% of abdominal wall transplant recipients will experience at least one episode of acute rejection in the first year after transplant, compared with rejection rates of 87.8% and 72.7% for hand and face transplant respectively. Recent evidence suggests that combining a skin containing abdominal wall transplant with an intestinal transplant does not appear to increase sensitization or de novo donor-specific antibody formation. Summary: Published data suggests that abdominal wall transplantation is an effective safe solution to achieve primary closure of the abdomen after intestinal or multivisceral transplant. However, better data is needed to confirm observations made and to determine long-term outcomes, requiring standardized data collection and reporting and collaboration between the small number of active transplant centres around the world.
AB - Purpose of Review: This article aims to review published outcomes associated with full-thickness vascularized abdominal wall transplantation, with particular emphasis on advances in the field in the last 3 years. Recent Findings: Forty-six full-thickness vascularized abdominal wall transplants have been performed in 44 patients worldwide. Approximately 35% of abdominal wall transplant recipients will experience at least one episode of acute rejection in the first year after transplant, compared with rejection rates of 87.8% and 72.7% for hand and face transplant respectively. Recent evidence suggests that combining a skin containing abdominal wall transplant with an intestinal transplant does not appear to increase sensitization or de novo donor-specific antibody formation. Summary: Published data suggests that abdominal wall transplantation is an effective safe solution to achieve primary closure of the abdomen after intestinal or multivisceral transplant. However, better data is needed to confirm observations made and to determine long-term outcomes, requiring standardized data collection and reporting and collaboration between the small number of active transplant centres around the world.
KW - Abdominal wall transplant
KW - Intestinal transplant
KW - Multivisceral transplant
KW - Vascularized composite allograft
UR - http://www.scopus.com/inward/record.url?scp=85096145712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096145712&partnerID=8YFLogxK
U2 - 10.1007/s40472-020-00308-9
DO - 10.1007/s40472-020-00308-9
M3 - Review article
AN - SCOPUS:85096145712
SN - 2196-3029
VL - 7
SP - 279
EP - 290
JO - Current Transplantation Reports
JF - Current Transplantation Reports
IS - 4
ER -